Keywords
early diagnostics
vasculitis
aortoarteriitis
Categories
How to Cite
Abstract
Systemic vasculitis is a group of heterogeneous diseases characterized by inflammation of the vascular wall. They can be primary or arise in the context of another disease. Blood vessels of different sizes are affected, being mainly divided into small, medium and large vessels. Takayasu's arteritis is a vasculitis of the large blood vessels, most often affecting the aorta and its branches, subclavian arteries, iliac, femoral arteries and others. The presented clinical case concerns a woman with non-specific symptoms - low fever, sweating, weight loss, easy fatigue. After excluding an infectious genesis of the complaints, a diagnosis of Takayasu's Arteritis was made in the early phase of the disease as a result of Positron emission tomography. Corticosteroid and immunosuppressive therapy was started. When conducting a control PET, 20 months after the start of the therapy, a significant regression to absence of the findings from the imaging study was observed.
References
Guillevin L, Dörner T. Vasculitis: mechanisms involved and clinical manifestations. Arthritis Res Ther. 2007; 9 Suppl 2 (Suppl 2): S9. doi: 10.1186/ar2193.
Jatwani S, Goyal A. Vasculitis. [Updated 2022 Aug 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK545186/
Jennette JC, Falk RJ, Bacon PA et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum. 2013; 65: 1-11. doi: 10.1002/art.37715.
Kerr GS, Hallahan CW, Giordano J et al. Takayasu arteritis. Ann Intern Med. 1994 Jun 1; 120 (11): 919-29. doi: 10.7326/0003-4819-120-11-199406010-00004.
Brunner J, Feldman BM, Tyrrell PN et al. Takayasu arteritis in children and adolescents. Rheumatol (Oxford). 2010 Oct; 49(10): 1806-14. doi: 10.1093/rheumatology/keq167.
Hall S, Barr W, Lie JT, et al. Takayasu arteritis. A study of 32 North American patients. Medicine. 1985; 64: 89-99.
Lupi-Herrera E, Sánchez-Torres G, Marcushamer J et al. Takayasu‘s arteritis. Clinical study of 107 cases. Am Heart J. 1977 Jan; 93(1): 94-103. doi: 10.1016/s0002-8703(77)80178-6.
Subramanyan R, Joy J, Balakrishnan KG. Natural history of aortoarteritis (Takayasu‘s disease). Circulation. 1989 Sep; 80(3): 429-37. doi: 10.1161/01.cir.80.3.429.
Li-xin Z, Jun N, Shan G et al. Neurological manifestations of Takayasu arteritis. Chin Med Sci J. 2011 Dec; 26(4): 227-30. doi: 10.1016/s1001-9294(12)60005-4.
Francès C, Boisnic S, Blétry O et al. Cutaneous manifestations of Takayasu arteritis. A retrospective study of 80 cases. Dermatologica. 1990; 181(4): 266-72. doi: 10.1159/000247820.
Arend WP, Michel BA, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990 Aug; 33(8): 1129-34. doi: 10.1002/art.1780330811.
Grayson PC, Ponte C, Suppiah R et al. 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. Ann Rheumatic Dis. 2022; 81: 1654-1660.
Trinidad B, Surmachevska N, Lala V. Takayasu Arteritis. [Updated 2022 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459127/
Schmidt WA, Nielsen BD. Imaging in large-vessel vasculitis. Best Pract Res Clin Rheumatol. 2020 Dec; 34(6): 101589. doi: 10.1016/j.berh.2020.101589.
Nielsen BD, Hansen IT, Keller KK et al. Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the reference. Rheumatol (Oxford). 2020 Aug 1; 59(8): 2062-2073.
Balink H, Bennink RJ, van Eck-Smit BL, Verberne HJ. The role of 18F-FDG PET/CT in large-vessel vasculitis: appropriateness of current classification criteria? BioMed Res Int. 2014; 2014: 1-13.
Slart RH et al. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imag. 2018; 45: 1250-1269.
Grayson PC, Alehashemi S, Bagheri AA, et al. 18F-Fluorodeoxyglucose-Positron emission tomography as an imaging biomarker in a prospective, longitudinal cohort of patients with large vessel vasculitis. Arthritis Rheum. 2018; 70: 439-449.
Dejaco C, Ramiro S, Duftner C, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheumatic Dis. 2018; 77: 636-643.
This work is licensed under a Creative Commons Attribution 4.0 International License.